Variability and factors influencing quality of life (QOL) in breast cancer patients having chemotherapy were examined in a longitudinal prospective cohort study in two teaching hospitals in China. Physical, mental, social/family, and functional QOL changed significantly over time with varying patterns. In addition, various factors influenced the QOL of breast cancer patients at each chemotherapy cycle. Health professionals should focus on critical time periods during chemotherapy, particularly at baseline and during the fourth and fifth cycles when the QOL in our sample was at the lowest point, and they should provide additional support to patients to ensure that chemotherapy is delivered in an optimal fashion.
BergerA. M.LockhartK.AgrawalS. (2009). Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncology Nursing Forum, 36, 563-570.
2.
ByarK. L.BergerA. M.BakkenS. L.CetakM. A. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncology Nursing Forum, 33(1), E18-26.
3.
CarayolM.DelpierreC.BernardP.NinotG. (2015). Population-, intervention- and methodology-related characteristics of clinical trials impact exercise efficacy during adjuvant therapy for breast cancer: A meta-regression analysis. Psycho-Oncology, 24, 737-747.
4.
CleelandC. S.MendozaT. R.WangX. S.ChouC.HarleM. T.MorrisseyM.EngstromM. C. (2000). Assessing symptom distress in cancer patients. Cancer, 89, 1634-1646.
5.
DaldoulA.KhechineW.BhiriH.AmmarN.BourigaR.KrirM.. . . ZaiedS. (2018). Factors predictive of quality of life among breast cancer patients. Asian Pacific Journal of Cancer Prevention, 19, 1671-1675.
6.
da Mata TiezziM. F. B.de AndradeJ. M.RomãoA. P. M. S.TiezziD. G.LerriM. R.CarraraH. A. H.LaraL. A. S. (2017). Quality of life in women with breast cancer treated with or without chemotherapy. Cancer Nursing, 40, 108-116.
7.
Early Breast Cancer Trialists’ Collaborative Group. (2012). Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. The Lancet, 379, 432-444.
8.
FangQ.WuQ.ZhangX.MaX. (2012). Analysis of the prevalence of the breast cancer. Chinese Journal of Social Medicine, 29, 333-335.
9.
FisherH. M.JacobsJ.TaubC. J.LechnerS.LewisJ. E.CarverC. S.. . . AntoniM. H. (2017). How changes in physical activity relate to fatigue interference, mood, and quality of life during treatment for non-metastatic breast cancer. General Hospital Psychiatry, 49, 37-43.
10.
GauthierL.DworkinR.WarrD.Pillai RiddellR.MacphersonA.RodinG.. . . GaglieseL. (2018). Age-related patterns in cancer pain and its psychosocial impact: Investigating the role of variability in physical and mental health quality of life. Pain Medicine, 19, 658-676.
11.
HamerJ.McDonaldR.ZhangL.VermaS.LeaheyA.EcclestoneC.. . . ChowE. (2017). Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Supportive Care in Cancer, 25, 409-419.
12.
JacobL.KalderM.KostevK. (2017). Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany. Psycho-Oncology, 26, 1535-1540.
13.
LiuL.FiorentinoL.RisslingM.NatarajanL.ParkerB.DimsdaleJ.. . . Ancoli-IsraelS. (2013). Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behavioral Sleep Medicine, 11, 189-206.
14.
MackeyJ. R.MartinM.PienkowskiT.RolskiJ.GuastallaJ.-P.SamiA.. . . FornanderT. (2013). Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. The Lancet Oncology, 14, 72-80.
15.
MartinM.LluchA.SeguiM.RuizA.RamosM.AdroverE.. . . Fernandez-ChaconC. (2006). Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): Impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Annals of Oncology, 17, 1205-1212.
16.
MatikasA.MargolinS.HellströmM.JohanssonH.BengtssonN.KarlssonL.. . . BerghJ. (2018). Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer. Breast Cancer Research and Treatment, 168, 349-355.
17.
McFarlandD.ShafferK.TierstenA.HollandJ. (2018). Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer. Psycho-Oncology, 27, 1394-1403.
18.
MoulderS.HortobagyiG. (2008). Advances in the treatment of breast cancer. Clinical Pharmacology & Therapeutics, 83, 26-36.
19.
PopeZ. C.ZengN.ZhangR.LeeH.GaoZ. (2018). Effectiveness of combined smartwatch and social media intervention on breast cancer survivor health outcomes: A 10-week pilot randomized trial. Journal of Clinical Medicine, 7(6), Article 140.
20.
SalemC.AtallahD.SafiJ.ChahineG.HaddadA.El KassisN.. . . GhossainM. (2017). Breast density and breast cancer incidence in the Lebanese population: Results from a retrospective multicenter study. Biomed Research International, 2017. https://doi.org/10.1155/2017/7594953
21.
SalonenP.Kellokumpu-LehtinenP. L.TarkkaM. T.KoivistoA. M.KaunonenM. (2011). Changes in quality of life in patients with breast cancer. Journal of Clinical Nursing, 20, 255-266.
22.
SchmidtM. E.Chang-ClaudeJ.VrielingA.HeinzJ.Flesch-JanysD.SteindorfK. (2012). Fatigue and quality of life in breast cancer survivors: Temporal courses and long-term pattern. Journal of Cancer Survivorship, 6, 11-19.
23.
SultanA.ChoudharyV.ParganihaA. (2017). Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles. Chronobiology International, 34, 609-623.
24.
WanC.ZhangD.YangZ.TuX.TangW.FengC.. . . TangX. (2007). Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Research and Treatment, 106, 413-418.
ZhengL.WangY.LiH. (2003). Application of hospital anxiety and depression scale in general hospital an analysis in reliability and validity. Shanghai Archives of Psychiatry, 15, 264-266.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
